Bioactivity | Betamethasone 17-benzoate is a representative steroid, which can be used in the treatment of recurrent aphothous ulcers (RAU). |
Invitro | Betamethasone 17-benzoate is the topical steroid[1]. Betamethasone 17-benzoate is a local corticosteroid[2]. A double-blind study of the effectiveness of Betamethasone 17-benzoate in the treatment of recurrent aphothous ulcers (RAU) is concucted. Betamethasone 17-benzoate is found to be effective in reducing symptoms and shortening healing time but not in preventing recurrences[3]. |
Name | Betamethasone 17-benzoate |
CAS | 22298-29-9 |
Formula | C29H33FO6 |
Molar Mass | 496.57 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Barry BW, et al. Optimization of bioavailability of topical steroids: penetration enhancers under occlusion. J Invest Dermatol. 1984 Jan;82(1):49-52. [2]. ZFA (Stuttgart). 1978 Jul 10;54(19):1031-2. [3]. Merchant HW, et al. Betamethasone-17-benzoate in the treatment of recurrent aphthous ulcers. Oral Surg Oral Med Oral Pathol. 1978 Jun;45(6):870-5. |